Unprecedented guidelines from the American Society of Echocardiography take on suboptimal recognition of pericardial disease and help shape the rapid evolution of cardio-oncology.
Cleveland Clinic investigators are helping evaluate a new imaging technology that may better predict which breast masses are cancerous or benign. Opto-acoustic imaging uses hemoglobin concentration and relative oxygenation to differentiate between malignant and nonmalignant lesions.
Incomplete revascularization is common with PCI, and most studies suggest it is associated with a worse prognosis. Yet quantification of the extent and complexity of residual atherosclerosis after PCI was not performed until a score for assessing residual stenosis was developed in an afterstudy of the SYNTAX trial.
Care coordination has always been imperative in the healthcare industry, serving as a foundational center of medical practice for years. However, in the new healthcare environment, the topic is getting renewed attention as part of a widespread effort to help health systems better manage high-risk patients.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
The pain mentor program trains nurses to help manage patients in pain through pharmacologic and non-pharmacologic methods and serve as a resource to bedside nurses.
Cleveland Clinic encourages nurses to participate in conferences at the local, regional and national level.
Liver surgery is becoming safer, thanks to 3-D modeling. This technology is now helping surgeons plan surgeries and helping train tomorrow’s surgeons.
For symptoms of heart failure or hemolytic anemia in a patient with a prosthetic heart valve, think paravalvular leak. Then consider a percutaneous approach for less-invasive repair.
Learn about featured clinical trials currently enrolling or search our trials database.
Hyperthermic intraperitoneal chemotherapy, which involves the intraoperative delivery and circulation of heated cancer drugs, is showing promise for cancers of the peritoneal cavity arising from gynecologic cancers. The technique is a welcome development in the treatment of a disease whose outcome has changed little in the past two decades.